News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Aveo, Astellas end pact to develop cancer drug tivozanib

Started by riky, February 15, 2014, 09:00:15 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Aveo, Astellas end pact to develop cancer drug tivozanib

<p><a href="http://news.yahoo.com/aveo-astellas-end-pact-develop-cancer-drug-tivozanib-114215958--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/Kwjya43EijDYZYweErVJzQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-02-14T114215Z_1_CBREA1D0WII00_RTROPTP_2_JAPAN.JPG" width="130" height="86" alt="Logo of Astellas Pharma Inc. is seen at the company's headquarters in Tokyo" align="left" title="Logo of Astellas Pharma Inc. is seen at the company's headquarters in Tokyo" border="0" /></a>(Reuters) - Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug that has seen a string of failures in multiple cancer indications. Aveo, which cut 62 percent of its workforce last year to focus on developing the drug, tivozanib, as a treatment for breast and colon cancers, said in December that the drug was not likely to succeed in a mid-stage trial testing its use in colon cancer. A mid-stage trial testing tivozanib as a treatment for breast cancer was stopped last month due to insufficient enrolments. Tivozanib was rejected by U.S. health regulators in June for use in kidney cancer, citing inconsistent study results.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login